請 GPT-4 依據 RoB 2 評估 REVIVAL

請 GPT-4 依據 RoB 2 評估

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) 23

https://link.springer.com/article/10.1007/s00134-023-07271-w


1.**隨機化過程產生的偏差**：

   - 該試驗在這方面的偏倚風險較低。隨機化的方法是適當的，採用了帶分層的包塊隨機化方案。這種方法與隱藏機制（交互式語音/網絡應答系統）相結合，最大限度地降低了分配過程中出現偏差的風險。


2.**偏離預期干預措施造成的偏差**：

   - 這方面的偏差風險似乎也很低。試驗是雙盲的，所有研究人員對治療分配都是盲的。干預措施的定義和實施都很嚴格，降低了偏離預期干預措施的風險。


3.由於結果數據缺失造成的**偏倚**：

   - 論文沒有明確提到結果數據缺失的程度。不過，考慮到數據收集和分析的嚴格方法，結果數據缺失導致偏差的風險可能很低。修改後的意向治療分析進一步支持了這一評估。


4.**結果測量的偏差**：

   - 這一領域的偏倚風險也很低。研究結果定義明確，而且對參與者、工作人員和結果評估者都進行了盲法處理，因此測量偏差的風險應該降到最低。


5.**報告結果的選擇偏倚**：

   - 這項試驗的偏倚風險似乎較低。主要和次要結果是預先指定的，沒有跡象表明結果報告存在選擇性。該試驗對其方案和統計分析計劃的遵守也支持這一評估。


總體而言，在 RoB 2 工具評估的各個領域中似乎偏倚風險較低。研究的設計、執行和報告都展示了一種嚴格的方法，可最大限度地減少隨機對照試驗中通常會遇到的潛在偏倚。

留言

張貼留言

這個網誌中的熱門文章

Bayesian reanalysis of ORBITA

import pymc3 as pm import numpy as np import arviz as az # Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial 18 https://www.sciencedirect.com/science/article/abs/pii/S0140673617327149 diff = 16.6 diff_lower = -8.9 diff_upper = 42 # The scale for the Cauchy distribution cauchy_scale = 5 # Model setup with pm.Model() as model:     # Prior distribution for the difference     diff_prior = pm.Cauchy("diff", alpha=0, beta=cauchy_scale)      # Likelihood (normal approximation of the distribution of the difference)     se_diff = (diff_upper - diff_lower) / 3.92     likelihood = pm.Normal("likelihood", mu=diff_prior, sigma=se_diff, observed=np.array([diff]))     # Sample from the posterior distribution     trace = pm.sample(500000, cores=1, tune=200000, chains=4) # Calculate the posterior probability that the difference is negative post_prob_diff_negative = np.mean(t...
閱讀完整內容

Bayesian reanalysis with pymc3

 # Empagliflozin after Acute Myocardial Infarction 24 https://www.nejm.org/doi/full/10.1056/NEJMoa2314051 Do a Bayesian reanalysis of a RCT for log(hazard ratio) with 500000 samplings with a weakly informative prior, calculate the probability of hazard ratio less than 1 and a sensitivity analysis using pymc3 and only show the results in traditional Chinese instead of the code: A total of 3260 patients were assigned to receive empagliflozin and 3262 to receive placebo. During a median follow-up of 17.9 months, a first hospitalization for heart failure or death from any cause occurred in 267 patients (8.2%) in the empagliflozin group and in 298 patients (9.1%) in the placebo group, with incidence rates of 5.9 and 6.6 events, respectively, per 100 patient-years (hazard ratio, 0.90; 95% confidence interval [CI], 0.76 to 1.06; P=0.21). 使用 pymc3 對一項 RCT 進行貝氏再分析，在弱信息先驗條件下抽樣 500000 次，計算危害比小於 1 的概率，並進行敏感性分析，只用繁體中文顯示結果，而不顯示代碼:  Do a Bayesian reanalysis of a RCT with 500000 samplings wit...
閱讀完整內容

Bayesian reanalysis of Apolipoprotein A1 Infusions

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction 24 https://www.nejm.org/doi/full/10.1056/NEJMoa2400969 P(θ | D) = (P(D | θ) * P(θ)) / P(D) marginal likelihood P(D) = ∫ P(D | θ) * P(θ) dθ Likelihood: P(D | θ) ~ N(μ_l, σ_l^2) Likelihood ratio: (P(D | θ1))/(P(D | θ2)*) Bayes factor: (P(D | θ1)* P(θ1))/(P(D | θ2)* P(θ2)) Prior: P(θ) ~ N(μ_p, σ_p^2) P(θ | D) ∝ P(D | θ) * P(θ) When we normalize the product of the two PDFs by dividing by the marginal likelihood p(D), the constant term cancels out, and we are left with a normal distribution with mean μ_new and variance σ_new^2. Prior mean 0, sd 0.5 log(HR) = log(0.93) = -0.0726 SE = (log(1.05) - log(0.81)) / (2 * 1.96) = 0.0644 Prior precision = 1 / (0.35^2) = 8.16 Likelihood precision = 1 / (0.0644^2) = 241.18 Posterior precision = 8.16 + 241.18 = 249.34 Posterior mean = (8.16 * 0 + 241.18 * -0.0726) / 249.34 = -0.0701 Posterior SD = sqrt(1 / 249.34) = 0.0634 Posterior 95% credible interval for the lo...
閱讀完整內容